\select@language {UKenglish}
\select@language {UKenglish}
\contentsline {chapter}{Glossary}{xix}{section*.4}
\contentsline {chapter}{Acronyms}{xxiii}{section*.6}
\contentsline {chapter}{\numberline {1}Introduction and Literature Review}{1}{chapter.1}
\contentsline {section}{\numberline {1.1}Cancer Research in the Post-Genomic Era}{1}{section.1.1}
\contentsline {subsection}{\numberline {1.1.1}Cancer is a Global Health Issue}{2}{subsection.1.1.1}
\contentsline {subsubsection}{\numberline {1.1.1.1}The Genetics and Molecular Biology of Cancers}{3}{subsubsection.1.1.1.1}
\contentsline {subsection}{\numberline {1.1.2}The Genomics Revolution in Cancer Research}{3}{subsection.1.1.2}
\contentsline {subsubsection}{\numberline {1.1.2.1}High-Throughput Technologies}{4}{subsubsection.1.1.2.1}
\contentsline {subsubsection}{\numberline {1.1.2.2}Bioinformatics and Genomic Data}{5}{subsubsection.1.1.2.2}
\contentsline {subsection}{\numberline {1.1.3}Genomics Projects}{5}{subsection.1.1.3}
\contentsline {subsubsection}{\numberline {1.1.3.1}The Cancer Genome Project}{6}{subsubsection.1.1.3.1}
\contentsline {subsubsection}{\numberline {1.1.3.2}The Cancer Genome Atlas Project}{6}{subsubsection.1.1.3.2}
\contentsline {subsection}{\numberline {1.1.4}Genomic Cancer Medicine}{8}{subsection.1.1.4}
\contentsline {subsubsection}{\numberline {1.1.4.1}Cancer Genes and Driver Mutations}{8}{subsubsection.1.1.4.1}
\contentsline {subsubsection}{\numberline {1.1.4.2}Precision Cancer Medicine}{9}{subsubsection.1.1.4.2}
\contentsline {subsubsection}{\numberline {1.1.4.3}Molecular Diagnostics and Pan-Cancer Medicine}{9}{subsubsection.1.1.4.3}
\contentsline {subsubsection}{\numberline {1.1.4.4}Targeted Therapeutics and Pharmacogenomics}{10}{subsubsection.1.1.4.4}
\contentsline {subsection}{\numberline {1.1.5}Systems and Network Biology}{11}{subsection.1.1.5}
\contentsline {section}{\numberline {1.2}Synthetic Lethal Cancer Medicine}{12}{section.1.2}
\contentsline {subsection}{\numberline {1.2.1}Synthetic Lethal Genetic Interactions}{13}{subsection.1.2.1}
\contentsline {subsection}{\numberline {1.2.2}Synthetic Lethal Concepts in Genetics}{13}{subsection.1.2.2}
\contentsline {subsection}{\numberline {1.2.3}Synthetic Lethality in Model Systems}{15}{subsection.1.2.3}
\contentsline {subsubsection}{\numberline {1.2.3.1}Synthetic Lethal Pathways and Networks}{15}{subsubsection.1.2.3.1}
\contentsline {subsubsection}{\numberline {1.2.3.2}Evolution of Synthetic Lethality}{16}{subsubsection.1.2.3.2}
\contentsline {subsection}{\numberline {1.2.4}Synthetic Lethality in Cancer}{17}{subsection.1.2.4}
\contentsline {subsection}{\numberline {1.2.5}Clinical Impact of Synthetic Lethality in Cancer}{18}{subsection.1.2.5}
\contentsline {subsection}{\numberline {1.2.6}High{}-throughput Screening for Synthetic Lethality}{20}{subsection.1.2.6}
\contentsline {subsubsection}{\numberline {1.2.6.1}Synthetic Lethal Screens}{21}{subsubsection.1.2.6.1}
\contentsline {subsection}{\numberline {1.2.7}Computational Prediction of Synthetic Lethality}{22}{subsection.1.2.7}
\contentsline {subsubsection}{\numberline {1.2.7.1}Bioinformatics Approaches to Genetic Interactions}{22}{subsubsection.1.2.7.1}
\contentsline {subsubsection}{\numberline {1.2.7.2}Comparative Genomics}{23}{subsubsection.1.2.7.2}
\contentsline {subsubsection}{\numberline {1.2.7.3}Analysis and Modelling of Protein Data}{26}{subsubsection.1.2.7.3}
\contentsline {subsubsection}{\numberline {1.2.7.4}Differential Gene Expression}{28}{subsubsection.1.2.7.4}
\contentsline {subsubsection}{\numberline {1.2.7.5}Data Mining and Machine Learning}{29}{subsubsection.1.2.7.5}
\contentsline {subsubsection}{\numberline {1.2.7.6}Mutual Exclusivity and Bimodality}{32}{subsubsection.1.2.7.6}
\contentsline {subsubsection}{\numberline {1.2.7.7}Rationale for Further Development}{33}{subsubsection.1.2.7.7}
\contentsline {section}{\numberline {1.3}E-cadherin as a Synthetic Lethal Target}{33}{section.1.3}
\contentsline {subsection}{\numberline {1.3.1}The \textit {CDH1} gene and its Biological Functions}{34}{subsection.1.3.1}
\contentsline {subsubsection}{\numberline {1.3.1.1}Cytoskeleton}{34}{subsubsection.1.3.1.1}
\contentsline {subsubsection}{\numberline {1.3.1.2}Extracellular and Tumour Micro-environment}{34}{subsubsection.1.3.1.2}
\contentsline {subsubsection}{\numberline {1.3.1.3}Cell-Cell Adhesion and Signalling}{35}{subsubsection.1.3.1.3}
\contentsline {subsection}{\numberline {1.3.2}\textit {CDH1} as a Tumour (and Invasion) Suppressor}{35}{subsection.1.3.2}
\contentsline {subsubsection}{\numberline {1.3.2.1}Breast Cancers and Invasion}{35}{subsubsection.1.3.2.1}
\contentsline {subsection}{\numberline {1.3.3}Hereditary Diffuse Gastric (and Lobular Breast) Cancer}{36}{subsection.1.3.3}
\contentsline {subsection}{\numberline {1.3.4}Cell Line Models of \textit {CDH1} Null Mutations}{37}{subsection.1.3.4}
\contentsline {section}{\numberline {1.4}Summary and Research Direction of Thesis}{38}{section.1.4}
\contentsline {subsection}{\numberline {1.4.1}Thesis Aims}{39}{subsection.1.4.1}
\contentsline {chapter}{\numberline {2}Methods and Resources}{41}{chapter.2}
\contentsline {section}{\numberline {2.1}Bioinformatics Resources for Genomics Research}{41}{section.2.1}
\contentsline {subsection}{\numberline {2.1.1}Public Data and Software Packages}{41}{subsection.2.1.1}
\contentsline {subsubsection}{\numberline {2.1.1.1}Cancer Genome Atlas Data}{42}{subsubsection.2.1.1.1}
\contentsline {subsubsection}{\numberline {2.1.1.2}Reactome and Annotation Data}{43}{subsubsection.2.1.1.2}
\contentsline {section}{\numberline {2.2}Data Handling}{43}{section.2.2}
\contentsline {subsection}{\numberline {2.2.1}Normalisation}{43}{subsection.2.2.1}
\contentsline {subsection}{\numberline {2.2.2}Sample Triage}{44}{subsection.2.2.2}
\contentsline {subsection}{\numberline {2.2.3}Metagenes and the Singular Value Decomposition}{44}{subsection.2.2.3}
\contentsline {subsection}{\numberline {2.2.4}Candidate Triage and Integration with Screen Data}{46}{subsection.2.2.4}
\contentsline {section}{\numberline {2.3}Techniques}{47}{section.2.3}
\contentsline {subsection}{\numberline {2.3.1}Statistical Procedures and Tests}{47}{subsection.2.3.1}
\contentsline {subsection}{\numberline {2.3.2}Gene Set Over-representation Analysis}{48}{subsection.2.3.2}
\contentsline {subsection}{\numberline {2.3.3}Clustering}{48}{subsection.2.3.3}
\contentsline {subsection}{\numberline {2.3.4}Heatmap}{48}{subsection.2.3.4}
\contentsline {subsection}{\numberline {2.3.5}Modelling and Simulations}{49}{subsection.2.3.5}
\contentsline {subsubsection}{\numberline {2.3.5.1}Receiver Operating Characteristic Curves}{50}{subsubsection.2.3.5.1}
\contentsline {subsection}{\numberline {2.3.6}Resampling Analysis}{50}{subsection.2.3.6}
\contentsline {section}{\numberline {2.4}Pathway Structure Methods}{51}{section.2.4}
\contentsline {subsection}{\numberline {2.4.1}Network and Graph Analysis}{51}{subsection.2.4.1}
\contentsline {subsection}{\numberline {2.4.2}Sourcing Graph Structure Data}{52}{subsection.2.4.2}
\contentsline {subsection}{\numberline {2.4.3}Constructing Pathway Subgraphs}{52}{subsection.2.4.3}
\contentsline {subsection}{\numberline {2.4.4}Network Analysis Metrics}{53}{subsection.2.4.4}
\contentsline {section}{\numberline {2.5}Implementation}{54}{section.2.5}
\contentsline {subsection}{\numberline {2.5.1}Computational Resources and Linux Utilities}{54}{subsection.2.5.1}
\contentsline {subsection}{\numberline {2.5.2}R Language and Packages}{55}{subsection.2.5.2}
\contentsline {subsection}{\numberline {2.5.3}High Performance and Parallel Computing}{58}{subsection.2.5.3}
\contentsline {chapter}{\numberline {3}Methods Developed During Thesis}{60}{chapter.3}
\contentsline {section}{\numberline {3.1}A Synthetic Lethal Detection Methodology}{60}{section.3.1}
\contentsline {section}{\numberline {3.2}Synthetic Lethal Simulation and Modelling}{62}{section.3.2}
\contentsline {subsection}{\numberline {3.2.1}A Model of Synthetic Lethality in Expression Data}{63}{subsection.3.2.1}
\contentsline {subsection}{\numberline {3.2.2}Simulation Procedure}{67}{subsection.3.2.2}
\contentsline {section}{\numberline {3.3}Detecting Simulated Synthetic Lethal Partners}{70}{section.3.3}
\contentsline {subsection}{\numberline {3.3.1}Binomial Simulation of Synthetic Lethality}{70}{subsection.3.3.1}
\contentsline {subsection}{\numberline {3.3.2}Multivariate Normal Simulation of Synthetic Lethality}{72}{subsection.3.3.2}
\contentsline {subsubsection}{\numberline {3.3.2.1}Multivariate Normal Simulation with Correlated Genes}{74}{subsubsection.3.3.2.1}
\contentsline {subsubsection}{\numberline {3.3.2.2}Specificity with Query-Correlated Pathways}{82}{subsubsection.3.3.2.2}
\contentsline {section}{\numberline {3.4}Graph Structure Methods}{84}{section.3.4}
\contentsline {subsection}{\numberline {3.4.1}Upstream and Downstream Gene Detection}{84}{subsection.3.4.1}
\contentsline {subsubsection}{\numberline {3.4.1.1}Permutation Analysis for Statistical Significance}{85}{subsubsection.3.4.1.1}
\contentsline {subsubsection}{\numberline {3.4.1.2}Hierarchy Based on Biological Context}{86}{subsubsection.3.4.1.2}
\contentsline {subsection}{\numberline {3.4.2}Simulating Gene Expression from Graph Structures}{87}{subsection.3.4.2}
\contentsline {section}{\numberline {3.5}Customised Functions and Packages Developed}{91}{section.3.5}
\contentsline {subsection}{\numberline {3.5.1}Synthetic Lethal Interaction Prediction Tool}{91}{subsection.3.5.1}
\contentsline {subsection}{\numberline {3.5.2}Data Visualisation}{92}{subsection.3.5.2}
\contentsline {subsection}{\numberline {3.5.3}Extensions to the iGraph Package}{94}{subsection.3.5.3}
\contentsline {subsubsection}{\numberline {3.5.3.1}Sampling Simulated Data from Graph Structures}{94}{subsubsection.3.5.3.1}
\contentsline {subsubsection}{\numberline {3.5.3.2}Plotting Directed Graph Structures}{94}{subsubsection.3.5.3.2}
\contentsline {subsubsection}{\numberline {3.5.3.3}Computing Information Centrality}{95}{subsubsection.3.5.3.3}
\contentsline {subsubsection}{\numberline {3.5.3.4}Testing Pathway Structure with Permutation Testing}{95}{subsubsection.3.5.3.4}
\contentsline {subsubsection}{\numberline {3.5.3.5}Metapackage to Install iGraph Functions}{96}{subsubsection.3.5.3.5}
\contentsline {chapter}{\numberline {4}Synthetic Lethal Analysis of Gene Expression Data}{97}{chapter.4}
\contentsline {section}{\numberline {4.1}Synthetic Lethal Genes in Breast Cancer}{98}{section.4.1}
\contentsline {subsection}{\numberline {4.1.1}Synthetic Lethal Pathways in Breast Cancer}{99}{subsection.4.1.1}
\contentsline {subsection}{\numberline {4.1.2}Expression Profiles of Synthetic Lethal Partners}{101}{subsection.4.1.2}
\contentsline {subsubsection}{\numberline {4.1.2.1}Subgroup Pathway Analysis}{104}{subsubsection.4.1.2.1}
\contentsline {section}{\numberline {4.2}Comparing Synthetic Lethal Gene Candidates}{106}{section.4.2}
\contentsline {subsection}{\numberline {4.2.1}Primary siRNA Screen Candidates}{106}{subsection.4.2.1}
\contentsline {subsection}{\numberline {4.2.2}Comparison with Correlation}{106}{subsection.4.2.2}
\contentsline {subsection}{\numberline {4.2.3}Comparison with Primary Screen Viability}{109}{subsection.4.2.3}
\contentsline {subsection}{\numberline {4.2.4}Comparison with Secondary siRNA Screen Validation}{111}{subsection.4.2.4}
\contentsline {subsection}{\numberline {4.2.5}Comparison to Primary Screen at Pathway Level}{112}{subsection.4.2.5}
\contentsline {subsubsection}{\numberline {4.2.5.1}Resampling Genes for Pathway Enrichment}{114}{subsubsection.4.2.5.1}
\contentsline {subsection}{\numberline {4.2.6}Integrating Synthetic Lethal Pathways and Screens}{119}{subsection.4.2.6}
\contentsline {section}{\numberline {4.3}Synthetic Lethal Pathway Metagenes}{120}{section.4.3}
\contentsline {section}{\numberline {4.4}Replication in Stomach Cancer}{122}{section.4.4}
\contentsline {section}{\numberline {4.5}Discussion}{123}{section.4.5}
\contentsline {subsection}{\numberline {4.5.1}Strengths of the SLIPT Methodology}{123}{subsection.4.5.1}
\contentsline {subsection}{\numberline {4.5.2}Synthetic Lethal Pathways for E-cadherin}{124}{subsection.4.5.2}
\contentsline {subsection}{\numberline {4.5.3}Replication and Validation}{126}{subsection.4.5.3}
\contentsline {subsubsection}{\numberline {4.5.3.1}Integration with siRNA Screening}{126}{subsubsection.4.5.3.1}
\contentsline {subsubsection}{\numberline {4.5.3.2}Replication across Tissues}{127}{subsubsection.4.5.3.2}
\contentsline {section}{\numberline {4.6}Summary}{127}{section.4.6}
\contentsline {chapter}{\numberline {5}Synthetic Lethal Pathway Structure}{129}{chapter.5}
\contentsline {section}{\numberline {5.1}Synthetic Lethal Genes in Reactome Pathways}{129}{section.5.1}
\contentsline {subsection}{\numberline {5.1.1}The PI3K/AKT Pathway}{130}{subsection.5.1.1}
\contentsline {subsection}{\numberline {5.1.2}The Extracellular Matrix}{132}{subsection.5.1.2}
\contentsline {subsection}{\numberline {5.1.3}G Protein Coupled Receptors}{135}{subsection.5.1.3}
\contentsline {subsection}{\numberline {5.1.4}Gene Regulation and Translation}{135}{subsection.5.1.4}
\contentsline {section}{\numberline {5.2}Network Analysis of Synthetic Lethal Genes}{136}{section.5.2}
\contentsline {subsection}{\numberline {5.2.1}Gene Connectivity and Vertex Degree}{136}{subsection.5.2.1}
\contentsline {subsection}{\numberline {5.2.2}Gene Importance and Centrality}{138}{subsection.5.2.2}
\contentsline {subsubsection}{\numberline {5.2.2.1}Information Centrality}{138}{subsubsection.5.2.2.1}
\contentsline {subsubsection}{\numberline {5.2.2.2}PageRank Centrality}{140}{subsubsection.5.2.2.2}
\contentsline {section}{\numberline {5.3}Upstream or Downstream Synthetic Lethality}{141}{section.5.3}
\contentsline {subsection}{\numberline {5.3.1}Measuring Structure of Candidates within PI3K}{142}{subsection.5.3.1}
\contentsline {subsection}{\numberline {5.3.2}Resampling for Synthetic Lethal Pathway Structure}{144}{subsection.5.3.2}
\contentsline {section}{\numberline {5.4}Discussion}{145}{section.5.4}
\contentsline {section}{\numberline {5.5}Summary}{147}{section.5.5}
\contentsline {chapter}{\numberline {6}Simulation and Modelling of Synthetic Lethal Pathways}{149}{chapter.6}
\contentsline {section}{\numberline {6.1}Synthetic Lethal Detection Methods}{150}{section.6.1}
\contentsline {subsection}{\numberline {6.1.1}Performance of SLIPT and $\chi ^2$ across Quantiles}{151}{subsection.6.1.1}
\contentsline {subsubsection}{\numberline {6.1.1.1}Correlated Query Genes affects Specificity}{154}{subsubsection.6.1.1.1}
\contentsline {subsection}{\numberline {6.1.2}Alternative Synthetic Lethal Detection Strategies}{156}{subsection.6.1.2}
\contentsline {subsubsection}{\numberline {6.1.2.1}Correlation for Synthetic Lethal Detection}{157}{subsubsection.6.1.2.1}
\contentsline {subsubsection}{\numberline {6.1.2.2}Testing for Bimodality with BiSEp}{158}{subsubsection.6.1.2.2}
\contentsline {section}{\numberline {6.2}Simulations with Graph Structures}{159}{section.6.2}
\contentsline {subsection}{\numberline {6.2.1}Performance over Graph Structures}{160}{subsection.6.2.1}
\contentsline {subsubsection}{\numberline {6.2.1.1}Simple Graph Structures}{160}{subsubsection.6.2.1.1}
\contentsline {subsubsection}{\numberline {6.2.1.2}Constructed Graph Structures}{163}{subsubsection.6.2.1.2}
\contentsline {subsection}{\numberline {6.2.2}Performance with Inhibitions}{165}{subsection.6.2.2}
\contentsline {subsection}{\numberline {6.2.3}Synthetic Lethality across Graph Structures}{171}{subsection.6.2.3}
\contentsline {subsection}{\numberline {6.2.4}Performance within a Simulated Human Genome}{174}{subsection.6.2.4}
\contentsline {section}{\numberline {6.3}Simulations in More Complex Graph Structures}{179}{section.6.3}
\contentsline {subsection}{\numberline {6.3.1}Simulations over Pathway-based Graphs}{180}{subsection.6.3.1}
\contentsline {subsection}{\numberline {6.3.2}Pathway Structures in a Simulated Human Genome}{182}{subsection.6.3.2}
\contentsline {section}{\numberline {6.4}Discussion}{185}{section.6.4}
\contentsline {subsection}{\numberline {6.4.1}Simulation Procedure}{185}{subsection.6.4.1}
\contentsline {subsection}{\numberline {6.4.2}Comparing Methods with Simulated Data}{186}{subsection.6.4.2}
\contentsline {subsection}{\numberline {6.4.3}Design and Performance of SLIPT}{187}{subsection.6.4.3}
\contentsline {subsection}{\numberline {6.4.4}Simulations from Graph Structures}{189}{subsection.6.4.4}
\contentsline {section}{\numberline {6.5}Summary}{190}{section.6.5}
\contentsline {chapter}{\numberline {7}Discussion}{192}{chapter.7}
\contentsline {section}{\numberline {7.1}Synthetic Lethality and \textit {CDH1} Biology}{192}{section.7.1}
\contentsline {subsection}{\numberline {7.1.1}Established Functions of \textit {CDH1}}{193}{subsection.7.1.1}
\contentsline {subsection}{\numberline {7.1.2}The Molecular Role of \textit {CDH1} in Cancer}{193}{subsection.7.1.2}
\contentsline {section}{\numberline {7.2}Significance}{194}{section.7.2}
\contentsline {subsection}{\numberline {7.2.1}Synthetic Lethality in the Genomic Era}{194}{subsection.7.2.1}
\contentsline {subsection}{\numberline {7.2.2}Clinical Interventions based on Synthetic Lethality}{196}{subsection.7.2.2}
\contentsline {section}{\numberline {7.3}Future Directions}{197}{section.7.3}
\contentsline {section}{\numberline {7.4}Conclusions}{199}{section.7.4}
\contentsline {chapter}{\hbox to\@tempdima {\hfil }Bibliography}{201}{section.7.4}
\contentsline {chapter}{\numberline {A}Sample Quality}{225}{appendix.A}
\contentsline {section}{\numberline {A.1}Sample Correlation}{225}{section.A.1}
\contentsline {section}{\numberline {A.2}Replicate Samples in TCGA Breast Cancer Data}{227}{section.A.2}
\contentsline {chapter}{\numberline {B}Software Used for Thesis}{231}{appendix.B}
\contentsline {chapter}{\numberline {C}Mutation Analysis in Breast Cancer}{240}{appendix.C}
\contentsline {section}{\numberline {C.1}Synthetic Lethal Genes and Pathways}{240}{section.C.1}
\contentsline {section}{\numberline {C.2}Synthetic Lethal Expression Profiles}{243}{section.C.2}
\contentsline {section}{\numberline {C.3}Comparison to Primary Screen}{246}{section.C.3}
\contentsline {subsection}{\numberline {C.3.1}Resampling Analysis}{248}{subsection.C.3.1}
\contentsline {section}{\numberline {C.4}Compare SLIPT genes}{250}{section.C.4}
\contentsline {chapter}{\numberline {D}Metagene Analysis}{252}{appendix.D}
\contentsline {section}{\numberline {D.1}Pathway Signature Expression}{252}{section.D.1}
\contentsline {section}{\numberline {D.2}Somatic Mutation}{261}{section.D.2}
\contentsline {section}{\numberline {D.3}Synthetic Lethal Reactome Metagenes}{262}{section.D.3}
\contentsline {section}{\numberline {D.4}Expression of Somatic Mutations}{264}{section.D.4}
\contentsline {chapter}{\numberline {E}Intrinsic Subtyping}{267}{appendix.E}
\contentsline {chapter}{\numberline {F}Stomach Expression Analysis}{269}{appendix.F}
\contentsline {section}{\numberline {F.1}Synthetic Lethal Genes and Pathways}{269}{section.F.1}
\contentsline {section}{\numberline {F.2}Comparison to Primary Screen}{273}{section.F.2}
\contentsline {subsection}{\numberline {F.2.1}Resampling Analysis}{275}{subsection.F.2.1}
\contentsline {section}{\numberline {F.3}Metagene Analysis}{277}{section.F.3}
\contentsline {chapter}{\numberline {G}Synthetic Lethal Genes in Pathways}{278}{appendix.G}
\contentsline {chapter}{\numberline {H}Pathway Connectivity for Mutation SLIPT}{286}{appendix.H}
\contentsline {chapter}{\numberline {I}Pathway Structure for Mutation SLIPT}{290}{appendix.I}
\contentsline {chapter}{\numberline {J}Performance of SLIPT and $\chi ^2$}{292}{appendix.J}
\contentsline {section}{\numberline {J.1}Correlated Query Genes affects Specificity}{298}{section.J.1}
\contentsline {chapter}{\numberline {K}Simulations on Graph Structures}{304}{appendix.K}
\contentsline {subsection}{\numberline {K.0.1}Simulations from Inhibiting Graph Structures}{305}{subsection.K.0.1}
\contentsline {section}{\numberline {K.1}Simulation across Graph Structures}{308}{section.K.1}
\contentsline {section}{\numberline {K.2}Simulations from Complex Graph Structures}{312}{section.K.2}
\contentsline {subsection}{\numberline {K.2.1}Simulations from Complex Inhibiting Graphs}{315}{subsection.K.2.1}
\contentsline {section}{\numberline {K.3}Simulations from Pathway Graph Structures}{321}{section.K.3}
